$ACFN
ACORN ENERGY, INC. Stock $acfn

$acfn Overview Financials Valuation SEC Filings Company Website

2023 Q1 Form 10-K Financial Statement

#000149315223007830 Filed on March 16, 2023

Income Statement

Concept	2023 Q1	2022 Q4	2022
Revenue	$1.749M	$1.845M	$7.000M
YoY Change	-0.11%	5.19%	3.31%
Cost Of Revenue	$433.0K	$493.0K	$1.929M
YoY Change	-12.17%	-6.81%	2.77%
Gross Profit	$1.316M	$1.352M	$5.071M
YoY Change	4.61%	10.37%	3.51%
Gross Profit Margin	75.24%	73.28%	72.44%
Selling, General & Admin	$1.197M	$1.219M	$4.804M
YoY Change	1.27%	12.66%	15.26%
% of Gross Profit	90.96%	90.16%	94.73%
Research & Development	$214.0K	$208.0K	$845.0K
YoY Change	8.08%	0.48%	14.34%
% of Gross Profit	16.26%	15.38%	16.66%
Depreciation & Amortization	$38.00K	$39.00K	$122.0K
YoY Change	90.0%	105.26%	62.67%
% of Gross Profit	2.89%	2.88%	2.41%
Operating Expenses	$1.411M	$1.427M	$5.700M
YoY Change	2.25%	10.71%	16.16%
Operating Profit	-$95.00K	-$75.00K	-$629.0K
YoY Change	-22.13%	17.19%	7762.5%
Interest Expense		-$1.000K	-$2.000K
YoY Change			-60.0%
% of Operating Profit
Other Income/Expense, Net	$11.00K
YoY Change
Pretax Income	-$84.00K	-$76.00K	-$631.0K
YoY Change	-31.15%	18.75%	4753.85%
Income Tax		$0.00
% Of Pretax Income
Net Earnings	-$85.00K	-$77.00K	-$633.0K
YoY Change	-30.33%	16.67%	2914.29%
Net Earnings / Revenue	-4.86%	-4.17%	-9.04%
Basic Earnings Per Share	$0.00		-$0.02
Diluted Earnings Per Share	$0.00	$0.00	-$0.02
COMMON SHARES
Basic Shares Outstanding	39.76M shares	39.71M shares	39.70K shares
Diluted Shares Outstanding	39.73K shares		39.70K shares

Balance Sheet

Concept	2023 Q1	2022 Q4	2022
SHORT-TERM ASSETS
Cash & Short-Term Investments	$1.346M	$1.450M	$1.450M
YoY Change	-24.55%	-15.8%	-15.8%
Cash & Equivalents	$1.346M	$1.450M	$1.450M
Short-Term Investments
Other Short-Term Assets	$312.0K	$288.0K	$1.175M
YoY Change	-70.54%	25.76%	14.3%
Inventory	$804.0K	$789.0K	$789.0K
Prepaid Expenses
Receivables	$771.0K	$597.0K	$597.0K
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$4.131M	$4.011M	$4.011M
YoY Change	-4.75%	-5.47%	-5.47%
LONG-TERM ASSETS
Property, Plant & Equipment	$641.0K	$653.0K	$951.0K
YoY Change	-37.77%	26.31%	3.82%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$211.0K	$215.0K	$1.022M
YoY Change	-78.47%	27.22%	15.74%
Total Long-Term Assets	$1.883M	$1.973M	$1.973M
YoY Change	-6.32%	9.67%	9.67%
TOTAL ASSETS
Total Short-Term Assets	$4.131M	$4.011M	$4.011M
Total Long-Term Assets	$1.883M	$1.973M	$1.973M
Total Assets	$6.014M	$5.984M	$5.984M
YoY Change	-5.25%	-0.96%	-0.96%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$361.0K	$243.0K	$243.0K
YoY Change	-30.04%	-46.83%	-46.83%
Accrued Expenses	$137.0K	$171.0K	$287.0K
YoY Change	-59.23%	4.27%	5.9%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$4.711M	$4.572M	$4.572M
YoY Change	3.79%	6.25%	6.25%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$18.00K	$16.00K	$2.423M
YoY Change	-99.24%	-99.27%	10.14%
Total Long-Term Liabilities	$2.377M	$2.423M	$2.423M
YoY Change	0.68%	10.14%	10.14%
TOTAL LIABILITIES
Total Short-Term Liabilities	$4.711M	$4.572M	$4.572M
Total Long-Term Liabilities	$2.377M	$2.423M	$2.423M
Total Liabilities	$7.088M	$6.995M	$7.001M
YoY Change	2.61%	7.57%	7.53%
SHAREHOLDERS EQUITY
Retained Earnings	-$101.4M	-$101.3M
YoY Change		0.63%
Common Stock	$103.3M	$103.3M
YoY Change		0.08%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$3.036M	$3.036M
YoY Change		0.0%
Treasury Stock Shares		801.9K shares
Shareholders Equity	-$1.080M	-$1.017M	-$1.017M
YoY Change
Total Liabilities & Shareholders Equity	$6.014M	$5.984M	$5.984M
YoY Change	-5.25%	-0.96%	-0.96%

Cashflow Statement

Concept	2023 Q1	2022 Q4	2022
OPERATING ACTIVITIES
Net Income	-$85.00K	-$77.00K	-$633.0K
YoY Change	-30.33%	16.67%	2914.29%
Depreciation, Depletion And Amortization	$38.00K	$39.00K	$122.0K
YoY Change	90.0%	105.26%	62.67%
Cash From Operating Activities	-$83.00K	$342.0K	$31.00K
YoY Change	-137.56%	-279.06%	-76.52%
INVESTING ACTIVITIES
Capital Expenditures	$26.00K	$16.00K	$308.0K
YoY Change	-116.35%	-115.53%	-195.06%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities	-$26.00K	-$16.00K	-$308.0K
YoY Change	-83.65%	-84.47%	-4.94%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	$5.000K	0.000	$5.000K
YoY Change			-103.36%
NET CHANGE
Cash From Operating Activities	-$83.00K	342.0K	$31.00K
Cash From Investing Activities	-$26.00K	-16.00K	-$308.0K
Cash From Financing Activities	$5.000K	0.000	$5.000K
Net Change In Cash	-$104.0K	326.0K	-$272.0K
YoY Change	-267.74%	-210.88%	-20.23%
FREE CASH FLOW
Cash From Operating Activities	-$83.00K	$342.0K	$31.00K
Capital Expenditures	$26.00K	$16.00K	$308.0K
Free Cash Flow	-$109.0K	$326.0K	-$277.0K
YoY Change	-128.68%	-470.45%	-160.75%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022	dei	Entity Central Index Key EntityCentralIndexKey	0000880984
CY2022	dei	Amendment Flag AmendmentFlag	false
CY2022	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2022	dei	Document Annual Report DocumentAnnualReport	true
CY2022	dei	Document Transition Report DocumentTransitionReport	false
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2021Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2021	ACFN	Impairment Of Software ImpairmentOfSoftware		usd
CY2022	us-gaap	Proceeds From Short Term Debt ProceedsFromShortTermDebt		usd
CY2021	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised		usd
CY2022	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
CY2021	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
CY2022	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants		shares
CY2021	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants		shares
CY2022	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements		shares
CY2021	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements		shares
CY2021	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised		shares
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate		pure
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate		pure
CY2021	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised		shares
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod		shares
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
CY2022	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations		pure
CY2021	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations		pure
CY2021Q4	ACFN	Deferred Tax Assets In Section Expenditures DeferredTaxAssetsInSectionExpenditures		usd
CY2022Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet		usd
CY2021Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet		usd
CY2021	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised		shares
CY2022	dei	Document Type DocumentType	10-K
CY2022	dei	Document Period End Date DocumentPeriodEndDate	2022-12-31
CY2022	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2022	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
CY2022	dei	Entity File Number EntityFileNumber	001-33886
CY2022	dei	Entity Registrant Name EntityRegistrantName	ACORN ENERGY, INC.
CY2022	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2022	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	22-2786081
CY2022	dei	Entity Address Address Line1 EntityAddressAddressLine1	1000 N West Street
CY2022	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 1200
CY2022	dei	Entity Address City Or Town EntityAddressCityOrTown	Wilmington
CY2022	dei	Entity Address State Or Province EntityAddressStateOrProvince	DE
CY2022	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	19801
CY2022	dei	City Area Code CityAreaCode	410
CY2022	dei	Local Phone Number LocalPhoneNumber	654-3315
CY2022	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2022	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2022	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2022	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2022	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2022	dei	Entity Small Business EntitySmallBusiness	true
CY2022	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2022	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2022	dei	Entity Shell Company EntityShellCompany	false
CY2022Q2	dei	Entity Public Float EntityPublicFloat	14500000	usd
CY2023Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	39757589	shares
CY2022	dei	Auditor Firm AuditorFirmId	688
CY2021	dei	Auditor Firm AuditorFirmId	711
CY2022	dei	Auditor Name AuditorName	Marcum LLP
CY2022	dei	Auditor Location AuditorLocation	Marlton New Jersey
CY2021	dei	Auditor Name AuditorName	Friedman LLP
CY2021	dei	Auditor Location AuditorLocation	Marlton, New Jersey
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1450000	usd
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1722000	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	597000	usd
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	876000	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	789000	usd
CY2021Q4	us-gaap	Inventory Net InventoryNet	617000	usd
CY2022Q4	us-gaap	Other Assets Current OtherAssetsCurrent	288000	usd
CY2021Q4	us-gaap	Other Assets Current OtherAssetsCurrent	229000	usd
CY2022Q4	us-gaap	Deferred Costs Current DeferredCostsCurrent	887000	usd
CY2021Q4	us-gaap	Deferred Costs Current DeferredCostsCurrent	799000	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	4011000	usd
CY2021Q4	us-gaap	Assets Current AssetsCurrent	4243000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	653000	usd
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	517000	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	298000	usd
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	399000	usd
CY2022Q4	us-gaap	Deferred Costs DeferredCosts	807000	usd
CY2021Q4	us-gaap	Deferred Costs DeferredCosts	714000	usd
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	215000	usd
CY2021Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	169000	usd
CY2022Q4	us-gaap	Assets Assets	5984000	usd
CY2021Q4	us-gaap	Assets Assets	6042000	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	243000	usd
CY2021Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	457000	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	171000	usd
CY2021Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	164000	usd
CY2022Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	3984000	usd
CY2021Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	3541000	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	116000	usd
CY2021Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	107000	usd
CY2022Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	58000	usd
CY2021Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	34000	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	4572000	usd
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	4303000	usd
CY2022Q4	us-gaap	Deferred Revenue DeferredRevenue	2187000	usd
CY2021Q4	us-gaap	Deferred Revenue DeferredRevenue	1852000	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	220000	usd
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	336000	usd
CY2022Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	16000	usd
CY2021Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	12000	usd
CY2022Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	2423000	usd
CY2021Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	2200000	usd
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	42000000	shares
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	42000000	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	39722589	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	39722589	shares
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	39687589	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	39687589	shares
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	397000	usd
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	397000	usd
CY2022Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	102889000	usd
CY2021Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	102804000	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-101267000	usd
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-100634000	usd
CY2022Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	801920	shares
CY2021Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	801920	shares
CY2022Q4	us-gaap	Treasury Stock Value TreasuryStockValue	3036000	usd
CY2021Q4	us-gaap	Treasury Stock Value TreasuryStockValue	3036000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-1017000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	-469000	usd
CY2022Q4	us-gaap	Minority Interest MinorityInterest	6000	usd
CY2021Q4	us-gaap	Minority Interest MinorityInterest	8000	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-1011000	usd
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-461000	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	5984000	usd
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	6042000	usd
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	7000000	usd
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	6776000	usd
CY2022	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	1929000	usd
CY2021	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	1877000	usd
CY2022	us-gaap	Gross Profit GrossProfit	5071000	usd
CY2021	us-gaap	Gross Profit GrossProfit	4899000	usd
CY2022	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	845000	usd
CY2021	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	739000	usd
CY2022	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	4804000	usd
CY2021	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	4168000	usd
CY2022	us-gaap	Capitalized Computer Software Impairments1 CapitalizedComputerSoftwareImpairments1	51000	usd
CY2022	us-gaap	Operating Expenses OperatingExpenses	5700000	usd
CY2021	us-gaap	Operating Expenses OperatingExpenses	4907000	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-629000	usd
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	-8000	usd
CY2022	ACFN	Finance Income Expense Net FinanceIncomeExpenseNet	-2000	usd
CY2021	ACFN	Finance Income Expense Net FinanceIncomeExpenseNet	-5000	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-631000	usd
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-13000	usd
CY2022	us-gaap	Profit Loss ProfitLoss	-631000	usd
CY2021	us-gaap	Profit Loss ProfitLoss	-13000	usd
CY2022	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	2000	usd
CY2021	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	8000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-633000	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-21000	usd
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.02
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.00
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	39698	shares
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	39688	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	39698	shares
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	39688	shares
CY2020Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-519000	usd
CY2021	us-gaap	Profit Loss ProfitLoss	-13000	usd
CY2021	ACFN	Accrued Dividend In Preferred Shares Of Subsidiary AccruedDividendInPreferredSharesOfSubsidiary	-4000	usd
CY2021	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	75000	usd
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-461000	usd
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-461000	usd
CY2022	us-gaap	Profit Loss ProfitLoss	-631000	usd
CY2022	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	5000	usd
CY2022	us-gaap	Dividends Preferred Stock DividendsPreferredStock	4000	usd
CY2022	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	80000	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-1011000	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-1011000	usd
CY2022	us-gaap	Profit Loss ProfitLoss	-631000	usd
CY2021	us-gaap	Profit Loss ProfitLoss	-13000	usd
CY2022	us-gaap	Depreciation And Amortization DepreciationAndAmortization	122000	usd
CY2021	us-gaap	Depreciation And Amortization DepreciationAndAmortization	75000	usd
CY2022	ACFN	Impairment Of Software ImpairmentOfSoftware	51000	usd
CY2022	us-gaap	Asset Impairment Charges AssetImpairmentCharges	41000	usd
CY2021	us-gaap	Asset Impairment Charges AssetImpairmentCharges	22000	usd
CY2022	ACFN	Noncash Lease Expense NoncashLeaseExpense	124000	usd
CY2021	ACFN	Noncash Lease Expense NoncashLeaseExpense	117000	usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	80000	usd
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	75000	usd
CY2022	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-279000	usd
CY2021	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	268000	usd
CY2022	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	213000	usd
CY2021	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	403000	usd
CY2022	ACFN	Increase Decrease In Deferred Cost Of Goods Sold IncreaseDecreaseInDeferredCostOfGoodsSold	181000	usd
CY2021	ACFN	Increase Decrease In Deferred Cost Of Goods Sold IncreaseDecreaseInDeferredCostOfGoodsSold	207000	usd
CY2022	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	105000	usd
CY2021	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	172000	usd
CY2022	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	778000	usd
CY2021	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	839000	usd
CY2022	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-130000	usd
CY2021	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-121000	usd
CY2022	ACFN	Increase Decrease In Other Current Liabilities And Noncurrent Liabilities IncreaseDecreaseInOtherCurrentLiabilitiesAndNoncurrentLiabilities	184000	usd
CY2021	ACFN	Increase Decrease In Other Current Liabilities And Noncurrent Liabilities IncreaseDecreaseInOtherCurrentLiabilitiesAndNoncurrentLiabilities	-188000	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	31000	usd
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	132000	usd
CY2022	us-gaap	Payments For Software PaymentsForSoftware	292000	usd
CY2021	us-gaap	Payments For Software PaymentsForSoftware	317000	usd
CY2022	us-gaap	Payments For Proceeds From Investments PaymentsForProceedsFromInvestments	16000	usd
CY2021	us-gaap	Payments For Proceeds From Investments PaymentsForProceedsFromInvestments	7000	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-308000	usd
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-324000	usd
CY2021	us-gaap	Proceeds From Short Term Debt ProceedsFromShortTermDebt	-149000	usd
CY2022	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	5000	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	5000	usd
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-149000	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-272000	usd
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-341000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	1722000	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	2063000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	1450000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	1722000	usd
CY2022	us-gaap	Interest Paid Net InterestPaidNet	2000	usd
CY2021	us-gaap	Interest Paid Net InterestPaidNet	6000	usd
CY2022	ACFN	Accrued Preferred Dividends AccruedPreferredDividends	4000	usd
CY2021	ACFN	Accrued Preferred Dividends AccruedPreferredDividends	4000	usd
CY2022	us-gaap	Nature Of Operations NatureOfOperations	<p id="xdx_804_eus-gaap--NatureOfOperations_z8ZasVzEfeBa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 1—<span id="xdx_82C_zE9vnswibngg">NATURE OF OPERATIONS</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a) Description of Business</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Acorn Energy, Inc. and its subsidiaries, OMX Holdings, Inc. and OmniMetrix, LLC (collectively, “Acorn” or “the Company”) is a Delaware corporation which is a holding company focused on technology-driven solutions for energy infrastructure asset management. The Company provides the following products and Internet of Things (“IoT”) applications and services through its OmniMetrix, LLC (“OmniMetrix”) subsidiary:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Power Generation (“PG”) monitoring. </b>OmniMetrix’s PG services provide wireless remote monitoring and control systems and IoT applications for residential and commercial/industrial power generation equipment. This includes our AIRGuard product, which remotely monitors and controls industrial air compressors and our Smart Annunciator product which is typically sold to commercial customers that require a visual representation of the generator’s status and has a touch-screen display that indicates the current state of that generator.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Cathodic Protection (“CP”) monitoring. </b>OmniMetrix’s CP services provide remote monitoring and control products for cathodic protection systems on oil and gas pipelines serving the gas utilities market and pipeline operators. The CP product lineup includes solutions to remotely monitor and control rectifiers, test stations and bonds. OmniMetrix also offers the industry’s first RAD<sup>TM </sup>(Remote AC Mitigation Disconnect) that mounts onto existing Solid-state Decouplers in the field and can remotely disconnect/connect these AC mitigation tools which can drastically reduce a company’s expense while increasing employee safety.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Acorn’s shares are traded on the OTCQB marketplace under the symbol ACFN.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">See Notes 11 and 12 for segment information and major customers.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b) Liquidity</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of December 31, 2022, the Company had $<span id="xdx_90D_eus-gaap--CashAndCashEquivalentsAtCarryingValue_iI_c20221231_ztqwYOM6sLJa" title="Cash and Cash Equivalents, at Carrying Value">1,450,000</span> of consolidated cash.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At December 31, 2022, the Company had a negative working capital of $<span id="xdx_909_ecustom--WorkingCapital_iI_c20221231_zKVdeQlBgRH2" title="Working capital">561,000</span>. Its working capital included $<span id="xdx_906_eus-gaap--CashAndCashEquivalentsAtCarryingValue_iI_c20221231_z5HCv706tPP6" title="Cash">1,450,000</span> of cash and deferred revenue of $<span id="xdx_903_eus-gaap--DeferredRevenueCurrent_iI_c20221231_zqgma6dgN9I3" title="Deferred revenue">3,984,000</span>. Such deferred revenue does not require a significant cash outlay for the revenue to be recognized. Net cash decreased during the year ended December 31, 2022 by $<span id="xdx_90C_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_iN_di_c20220101__20221231_z8pmLY2dOSUb">272,000</span>, of which $<span id="xdx_90C_eus-gaap--NetCashProvidedByUsedInOperatingActivities_c20220101__20221231_zxwXz8xQkk27">31,000</span> was provided by operating activities, $<span id="xdx_902_eus-gaap--NetCashProvidedByUsedInInvestingActivities_iN_di_c20220101__20221231_zyl6B0AZUB26">308,000</span> was used in investing activities, and $<span id="xdx_904_eus-gaap--NetCashProvidedByUsedInFinancingActivities_c20220101__20221231_zk9XSgbj9Xbd">5,000</span> was provided by financing activities.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of March 14, 2023, the Company had cash of $<span id="xdx_90C_eus-gaap--Cash_iI_c20230314__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zb7GcjRj6Aqd" title="Cash">1,480,000</span>. The Company believes that such cash, plus the cash generated from operations, will provide sufficient liquidity to finance the operating activities of Acorn and OmniMetrix at their current level of operations for the twelve months from the issuance of these audited consolidated financial statements in particular. The Company may, at some point, elect to obtain a new line of credit or other source of financing to fund additional investments in the business.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p>
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1450000	usd
CY2022Q4	ACFN	Working Capital WorkingCapital	561000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1450000	usd
CY2022Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	3984000	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-272000	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	31000	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-308000	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	5000	usd
CY2022	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<p id="xdx_840_eus-gaap--PriorPeriodReclassificationAdjustmentDescription_zA2jSRPkIgme" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><b><span id="xdx_869_zeujNbadh1Qk">Reclassifications</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; padding: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; padding: 0; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; padding: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; padding: 0; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain reclassifications have been made to the Company’s consolidated financial statements for the period ended December 31, 2021 to conform to the current year’s consolidated financial statement presentation. Approximately $<span id="xdx_906_eus-gaap--InventoryWriteDown_c20210101__20211231_zCKm0oMajbw2" title="Written off inventory">22,000</span> in inventory that was written off in 2021 was reclassed to its own line item to conform with current period presentation. There was no effect on total assets, equity or net loss.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; padding: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2021	us-gaap	Inventory Write Down InventoryWriteDown	22000	usd
CY2022	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_84D_eus-gaap--UseOfEstimates_zWr1VnVBTbGj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_863_zQHvfMQMnoXf">Use of Estimates in Preparation of Financial Statements</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of consolidated financial statements requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities as of the date of the consolidated financial statements, and the reported amounts of revenues and expenses during the reporting periods.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As applicable to these consolidated financial statements, the most significant estimates and assumptions relate to uncertainties with respect to income taxes, inventories, account receivable allowances, contingencies, revenue recognition, management’s projections and analyses of the possible impairments.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2022	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	3000	usd
CY2021	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	10000	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	10000	usd
CY2021Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	6000	usd
CY2022	us-gaap	Inventory Write Down InventoryWriteDown	41000	usd
CY2021	us-gaap	Inventory Write Down InventoryWriteDown	22000	usd
CY2022Q4	us-gaap	Capitalized Contract Cost Net CapitalizedContractCostNet	279000	usd
CY2021Q4	us-gaap	Capitalized Contract Cost Net CapitalizedContractCostNet	285000	usd
CY2022Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	336000	usd
CY2021Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	443000	usd
CY2022	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p id="xdx_844_eus-gaap--ConcentrationRiskCreditRisk_zU23hI3pbQZi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_868_zTPGpQ65tq66">Concentration of Credit Risk</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s financial instruments, which potentially subject the Company to concentrations of credit risk, consist principally of cash and trade accounts receivable. The Company’s cash was deposited with a U.S. bank and amounted to $<span id="xdx_905_eus-gaap--DepositAssets_iI_c20221231_zm0rdzADfBbe" title="Deposited cash and cash equivalents">1,450,000</span> at December 31, 2022. The Company does not believe there is significant risk of non-performance by these counterparties. See Note 11(d) with respect to revenue from significant customers and concentrations of trade accounts receivables.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2022Q4	us-gaap	Deposit Assets DepositAssets	1450000	usd
CY2022	us-gaap	Excise And Sales Taxes ExciseAndSalesTaxes	51000	usd
CY2021	us-gaap	Excise And Sales Taxes ExciseAndSalesTaxes	28000	usd
CY2022Q4	us-gaap	Income Tax Examination Penalties And Interest Accrued IncomeTaxExaminationPenaltiesAndInterestAccrued	0	usd
CY2021Q4	us-gaap	Income Tax Examination Penalties And Interest Accrued IncomeTaxExaminationPenaltiesAndInterestAccrued	0	usd
CY2022Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0	usd
CY2021Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0	usd
CY2022	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	979000	shares
CY2022	ACFN	Weighted Average Exercise Price Of Options And Warrants WeightedAverageExercisePriceOfOptionsAndWarrants	0.41	shares
CY2021	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	868000	shares
CY2021	ACFN	Weighted Average Exercise Price Of Options And Warrants WeightedAverageExercisePriceOfOptionsAndWarrants	0.38	shares
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-633000	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-21000	usd
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	39698	shares
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	39688	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	39698	shares
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	39688	shares
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.02
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.00
CY2022Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	336000	usd
CY2022Q4	us-gaap	Lessee Operating Lease Discount Rate LesseeOperatingLeaseDiscountRate	0.045	pure
CY2022Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	684000	usd
CY2021Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	577000	usd
CY2022Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	105000	usd
CY2021Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	40000	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	789000	usd
CY2021Q4	us-gaap	Inventory Net InventoryNet	617000	usd
CY2022Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	4000	usd
CY2021Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	0	usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	1394000	usd
CY2021Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	1136000	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	741000	usd
CY2021Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	619000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	653000	usd
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	517000	usd
CY2022	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	122000	usd
CY2021	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	75000	usd
CY2022Q4	us-gaap	Lessee Operating Lease Discount Rate LesseeOperatingLeaseDiscountRate	0.045	pure
CY2022Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P2Y8M23D
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	128000	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	129000	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	99000	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	356000	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	20000	usd
CY2022Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	336000	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	116000	usd
CY2021Q3	us-gaap	Sublease Income SubleaseIncome	2375	usd
CY2022Q4	us-gaap	Leasehold Improvements Gross LeaseholdImprovementsGross	6000	usd
CY2021Q3	ACFN	Estimated Sublease Payments EstimatedSubleasePayments	6100	usd
CY2021Q3	ACFN	Annual Service Cost AnnualServiceCost	2220	usd
CY2022Q4	ACFN	Finance Lease Liability Sublease Payments Due Next Twelve Months FinanceLeaseLiabilitySubleasePaymentsDueNextTwelveMonths	20000	usd
CY2022Q4	ACFN	Finance Lease Liability Sublease Payments Due Year Two FinanceLeaseLiabilitySubleasePaymentsDueYearTwo	28000	usd
CY2022Q4	ACFN	Finance Lease Liability Sublease Payments Due Year Three FinanceLeaseLiabilitySubleasePaymentsDueYearThree	29000	usd
CY2022Q4	ACFN	Finance Lease Liability Sublease Payments Due FinanceLeaseLiabilitySubleasePaymentsDue	77000	usd
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	39722589	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	39722589	shares
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2022	ACFN	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Options Grants In Period Issued ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueOptionsGrantsInPeriodIssued	54000	usd
CY2021	ACFN	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Options Grants In Period Issued ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueOptionsGrantsInPeriodIssued	89000	usd
CY2022	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	35000	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	16000	usd
CY2022Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	13000	usd
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	291000	usd
CY2021Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	217000	usd
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.018	pure
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.005	pure
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P3Y10M9D
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P4Y4M28D
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.937	pure
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.997	pure
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	0.37
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	0.38
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	833020	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.39
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	722501	shares
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.62
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	145770	shares
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0.55
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	232770	shares
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0.54
CY2022	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	35000	shares
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0.18
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	122251	shares
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	2.04
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	943790	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.42
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	833020	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.39
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	819001	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	0.41
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	557242	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	0.33
CY2022Q4	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions	943790	shares
CY2022Q4	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions	819001	shares
CY2022Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	33000	usd
CY2022	ACFN	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Weighted Average Remaining Contractual Term2 ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageRemainingContractualTerm2	P2M15D
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-631000	usd
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-13000	usd
CY2022	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2021	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	-0.03	pure
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	-1.21	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.18	pure
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	1	pure
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits	49000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits	1064000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	378000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	630000	usd
CY2022Q4	ACFN	Deferred Tax Assets In Section Expenditures DeferredTaxAssetsInSectionExpenditures	205000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	16021000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	15904000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	16653000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	17598000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	16653000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	17598000	usd
CY2022	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	-945000	usd
CY2022	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	35000	shares
CY2022	us-gaap	Related Party Transaction Expenses From Transactions With Related Party RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty	190000	usd
CY2021	us-gaap	Related Party Transaction Expenses From Transactions With Related Party RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty	48000	usd
CY2022	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	2	segments
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	7000000	usd
CY2022	us-gaap	Gross Profit GrossProfit	5071000	usd
CY2022	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	122000	usd
CY2022	ACFN	Segment Income Loss Before Income Taxes SegmentIncomeLossBeforeIncomeTaxes	382000	usd
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	6776000	usd
CY2021	us-gaap	Gross Profit GrossProfit	4899000	usd
CY2021	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	75000	usd
CY2021	ACFN	Segment Income Loss Before Income Taxes SegmentIncomeLossBeforeIncomeTaxes	936000	usd
CY2021Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	5393000	usd
CY2022	ACFN	Contract With Customer Liability Additions ContractWithCustomerLiabilityAdditions	6983000	usd
CY2022	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	-6205000	usd
CY2022Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	6171000	usd
CY2022	ACFN	Net Income Loss Before Income Taxes For Reportable Segments NetIncomeLossBeforeIncomeTaxesForReportableSegments	331000	usd
CY2021	ACFN	Net Income Loss Before Income Taxes For Reportable Segments NetIncomeLossBeforeIncomeTaxesForReportableSegments	921000	usd
CY2022	ACFN	Unallocated Cost Of Corporate Headquarters UnallocatedCostOfCorporateHeadquarters	962000	usd
CY2021	ACFN	Unallocated Cost Of Corporate Headquarters UnallocatedCostOfCorporateHeadquarters	934000	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-631000	usd
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-13000	usd
CY2022Q4	ACFN	Assets Of Subsidiary AssetsOfSubsidiary	5931000	usd
CY2021Q4	ACFN	Assets Of Subsidiary AssetsOfSubsidiary	5938000	usd
CY2022Q4	ACFN	Assets Of Corporate Headquarters AssetsOfCorporateHeadquarters	53000	usd
CY2021Q4	ACFN	Assets Of Corporate Headquarters AssetsOfCorporateHeadquarters	104000	usd
CY2022Q4	us-gaap	Assets Assets	5984000	usd
CY2021Q4	us-gaap	Assets Assets	6042000	usd
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	7000000	usd
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	6776000	usd
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	7000000	usd
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	6776000	usd
CY2022Q4	ACFN	Contract With Customer Liability Revenue Additions In Year One ContractWithCustomerLiabilityRevenueAdditionsInYearOne	3984000	usd
CY2022Q4	ACFN	Contract With Customer Liability Revenue Additions In Year Two ContractWithCustomerLiabilityRevenueAdditionsInYearTwo	1755000	usd
CY2022Q4	ACFN	Contract With Customer Liability Revenue Additions In Year Three ContractWithCustomerLiabilityRevenueAdditionsInYearThree	432000	usd
CY2022Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	6171000	usd
CY2020Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	4554000	usd
CY2020Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	4554000	usd
CY2021	ACFN	Contract With Customer Liability Additions ContractWithCustomerLiabilityAdditions	6725000	usd
CY2021	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	-5886000	usd
CY2021Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	5393000	usd
CY2021Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	5393000	usd
CY2021Q4	ACFN	Contract With Customer Liability Revenue Additions In Year One ContractWithCustomerLiabilityRevenueAdditionsInYearOne	3541000	usd
CY2021Q4	ACFN	Contract With Customer Liability Revenue Additions In Year Two ContractWithCustomerLiabilityRevenueAdditionsInYearTwo	1391000	usd
CY2021Q4	ACFN	Contract With Customer Liability Revenue Additions In Year Three ContractWithCustomerLiabilityRevenueAdditionsInYearThree	461000	usd
CY2021Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	5393000	usd
CY2021Q4	us-gaap	Deferred Sales Inducements Net DeferredSalesInducementsNet	1513000	usd
CY2022	ACFN	Contract With Customer Liability Additions Net Of Adjustments ContractWithCustomerLiabilityAdditionsNetOfAdjustments	1267000	usd
CY2022	ACFN	Contract With Customer Liability Sales Recognized ContractWithCustomerLiabilitySalesRecognized	-1086000	usd
CY2022Q4	us-gaap	Deferred Sales Inducements Net DeferredSalesInducementsNet	1694000	usd
CY2022Q4	ACFN	Contract With Customer Liability Recognized Cost Of Sales In Year One ContractWithCustomerLiabilityRecognizedCostOfSalesInYearOne	887000	usd
CY2022Q4	ACFN	Contract With Customer Liability Recognized Cost Of Sales In Year Two ContractWithCustomerLiabilityRecognizedCostOfSalesInYearTwo	616000	usd
CY2022Q4	ACFN	Contract With Customer Liability Recognized Cost Of Sales In Year Three ContractWithCustomerLiabilityRecognizedCostOfSalesInYearThree	191000	usd
CY2022Q4	ACFN	Contract With Customer Liability Recognized Cost Of Sales ContractWithCustomerLiabilityRecognizedCostOfSales	1694000	usd
CY2020Q4	us-gaap	Deferred Sales Inducements Net DeferredSalesInducementsNet	1306000	usd
CY2020Q4	us-gaap	Deferred Sales Inducements Net DeferredSalesInducementsNet	1306000	usd
CY2021	ACFN	Contract With Customer Liability Additions Net Of Adjustments ContractWithCustomerLiabilityAdditionsNetOfAdjustments	1155000	usd
CY2021	ACFN	Contract With Customer Liability Sales Recognized ContractWithCustomerLiabilitySalesRecognized	-948000	usd
CY2021Q4	us-gaap	Deferred Sales Inducements Net DeferredSalesInducementsNet	1513000	usd
CY2021Q4	us-gaap	Deferred Sales Inducements Net DeferredSalesInducementsNet	1513000	usd
CY2021Q4	ACFN	Contract With Customer Liability Recognized Cost Of Sales In Year One ContractWithCustomerLiabilityRecognizedCostOfSalesInYearOne	799000	usd
CY2021Q4	ACFN	Contract With Customer Liability Recognized Cost Of Sales In Year Two ContractWithCustomerLiabilityRecognizedCostOfSalesInYearTwo	507000	usd
CY2021Q4	ACFN	Contract With Customer Liability Recognized Cost Of Sales In Year Three ContractWithCustomerLiabilityRecognizedCostOfSalesInYearThree	207000	usd
CY2021Q4	ACFN	Contract With Customer Liability Recognized Cost Of Sales ContractWithCustomerLiabilityRecognizedCostOfSales	1513000	usd
CY2021Q4	ACFN	Contract With Customer Asset Sale Commission ContractWithCustomerAssetSaleCommission	295000	usd
CY2022	ACFN	Contract With Customer Asset Additions ContractWithCustomerAssetAdditions	288000	usd
CY2022	us-gaap	Amortization Of Deferred Sales Commissions AmortizationOfDeferredSalesCommissions	184000	usd
CY2022Q4	ACFN	Contract With Customer Asset Sale Commission ContractWithCustomerAssetSaleCommission	399000	usd
CY2020Q4	ACFN	Contract With Customer Asset Sale Commission ContractWithCustomerAssetSaleCommission	177000	usd
CY2020Q4	ACFN	Contract With Customer Asset Sale Commission ContractWithCustomerAssetSaleCommission	177000	usd
CY2021	ACFN	Contract With Customer Asset Additions ContractWithCustomerAssetAdditions	246000	usd
CY2021	us-gaap	Amortization Of Deferred Sales Commissions AmortizationOfDeferredSalesCommissions	128000	usd
CY2021Q4	ACFN	Contract With Customer Asset Sale Commission ContractWithCustomerAssetSaleCommission	295000	usd
CY2021Q4	ACFN	Contract With Customer Asset Sale Commission ContractWithCustomerAssetSaleCommission	295000	usd

Files In Submission

Name	View Source	Status
acfn-20221231_def.xml	Edgar Link	unprocessable
acfn-20221231_cal.xml	Edgar Link	unprocessable
acfn-20221231_lab.xml	Edgar Link	unprocessable
0001493152-23-007830-index-headers.html	Edgar Link	pending
0001493152-23-007830-index.html	Edgar Link	pending
0001493152-23-007830.txt	Edgar Link	pending
0001493152-23-007830-xbrl.zip	Edgar Link	pending
acfn-20221231.xsd	Edgar Link	pending
ex10-7.htm	Edgar Link	pending
ex21-1.htm	Edgar Link	pending
ex23-1.htm	Edgar Link	pending
ex23-2.htm	Edgar Link	pending
ex31-1.htm	Edgar Link	pending
ex31-2.htm	Edgar Link	pending
ex32-1.htm	Edgar Link	pending
ex32-2.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
form10-k.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
acfn-20221231_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
form10-k_htm.xml	Edgar Link	completed
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$ACFN
ACORN ENERGY, INC. Stock $acfn

2023 Q1 Form 10-K Financial Statement

#000149315223007830 Filed on March 16, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ACFN ACORN ENERGY, INC. Stock $acfn

2023 Q1 Form 10-K Financial Statement

#000149315223007830 Filed on March 16, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ACFN
ACORN ENERGY, INC. Stock $acfn